Suppression of hepatitis C virus replicon by TGF-β

Takayuki Murata, Takayuki Ohshima, Masashi Yamaji, Masahiro Hosaka, Yusuke Miyanari, Makoto Hijikata, Kunitada Shimotohno

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) is one of the major causative agents of liver diseases, such as liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Using an efficient HCV subgenomic replicon system, we demonstrate that transforming growth factor-beta (TGF-β) suppresses viral RNA replication and protein expression from the HCV replicon. We further show that the anti-viral effect of this cytokine is associated with cellular growth arrest in a manner dependent on Smad signaling, not mitogen-activated protein kinase (MAPK) signaling. These results suggest a novel insight into the mechanisms of liver diseases caused by HCV.

Original languageEnglish
Pages (from-to)407-417
Number of pages11
JournalVirology
Volume331
Issue number2
DOIs
Publication statusPublished - 20-01-2005
Externally publishedYes

Fingerprint

Replicon
Hepacivirus
Transforming Growth Factor beta
Liver Diseases
Viral RNA
Viral Proteins
Mitogen-Activated Protein Kinases
Liver Cirrhosis
Hepatocellular Carcinoma
Fibrosis
Cytokines
Inflammation
Growth

All Science Journal Classification (ASJC) codes

  • Virology

Cite this

Murata, T., Ohshima, T., Yamaji, M., Hosaka, M., Miyanari, Y., Hijikata, M., & Shimotohno, K. (2005). Suppression of hepatitis C virus replicon by TGF-β. Virology, 331(2), 407-417. https://doi.org/10.1016/j.virol.2004.10.036
Murata, Takayuki ; Ohshima, Takayuki ; Yamaji, Masashi ; Hosaka, Masahiro ; Miyanari, Yusuke ; Hijikata, Makoto ; Shimotohno, Kunitada. / Suppression of hepatitis C virus replicon by TGF-β. In: Virology. 2005 ; Vol. 331, No. 2. pp. 407-417.
@article{3d8412fd215f40f6b63751090bd1dadb,
title = "Suppression of hepatitis C virus replicon by TGF-β",
abstract = "Hepatitis C virus (HCV) is one of the major causative agents of liver diseases, such as liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Using an efficient HCV subgenomic replicon system, we demonstrate that transforming growth factor-beta (TGF-β) suppresses viral RNA replication and protein expression from the HCV replicon. We further show that the anti-viral effect of this cytokine is associated with cellular growth arrest in a manner dependent on Smad signaling, not mitogen-activated protein kinase (MAPK) signaling. These results suggest a novel insight into the mechanisms of liver diseases caused by HCV.",
author = "Takayuki Murata and Takayuki Ohshima and Masashi Yamaji and Masahiro Hosaka and Yusuke Miyanari and Makoto Hijikata and Kunitada Shimotohno",
year = "2005",
month = "1",
day = "20",
doi = "10.1016/j.virol.2004.10.036",
language = "English",
volume = "331",
pages = "407--417",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

Murata, T, Ohshima, T, Yamaji, M, Hosaka, M, Miyanari, Y, Hijikata, M & Shimotohno, K 2005, 'Suppression of hepatitis C virus replicon by TGF-β', Virology, vol. 331, no. 2, pp. 407-417. https://doi.org/10.1016/j.virol.2004.10.036

Suppression of hepatitis C virus replicon by TGF-β. / Murata, Takayuki; Ohshima, Takayuki; Yamaji, Masashi; Hosaka, Masahiro; Miyanari, Yusuke; Hijikata, Makoto; Shimotohno, Kunitada.

In: Virology, Vol. 331, No. 2, 20.01.2005, p. 407-417.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Suppression of hepatitis C virus replicon by TGF-β

AU - Murata, Takayuki

AU - Ohshima, Takayuki

AU - Yamaji, Masashi

AU - Hosaka, Masahiro

AU - Miyanari, Yusuke

AU - Hijikata, Makoto

AU - Shimotohno, Kunitada

PY - 2005/1/20

Y1 - 2005/1/20

N2 - Hepatitis C virus (HCV) is one of the major causative agents of liver diseases, such as liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Using an efficient HCV subgenomic replicon system, we demonstrate that transforming growth factor-beta (TGF-β) suppresses viral RNA replication and protein expression from the HCV replicon. We further show that the anti-viral effect of this cytokine is associated with cellular growth arrest in a manner dependent on Smad signaling, not mitogen-activated protein kinase (MAPK) signaling. These results suggest a novel insight into the mechanisms of liver diseases caused by HCV.

AB - Hepatitis C virus (HCV) is one of the major causative agents of liver diseases, such as liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Using an efficient HCV subgenomic replicon system, we demonstrate that transforming growth factor-beta (TGF-β) suppresses viral RNA replication and protein expression from the HCV replicon. We further show that the anti-viral effect of this cytokine is associated with cellular growth arrest in a manner dependent on Smad signaling, not mitogen-activated protein kinase (MAPK) signaling. These results suggest a novel insight into the mechanisms of liver diseases caused by HCV.

UR - http://www.scopus.com/inward/record.url?scp=11344275986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344275986&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2004.10.036

DO - 10.1016/j.virol.2004.10.036

M3 - Article

C2 - 15629783

AN - SCOPUS:11344275986

VL - 331

SP - 407

EP - 417

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -

Murata T, Ohshima T, Yamaji M, Hosaka M, Miyanari Y, Hijikata M et al. Suppression of hepatitis C virus replicon by TGF-β. Virology. 2005 Jan 20;331(2):407-417. https://doi.org/10.1016/j.virol.2004.10.036